Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Robot lets hospital patients 'Visit' home virtually

NCT ID NCT04899830

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a telepresence robot called COVEALINK 2 that allows patients hospitalized for at least 2 months to remotely control a robot in their own home. Using a smartphone app, patients could move the robot around and talk with family and friends. The goal was to see how acceptable and emotionally helpful this technology is for people with motor or cognitive disabilities.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

49 people

The number who actually took part.

Started

Oct 2020

Finished

Apr 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≧ 18 years old * Affiliation to a social security scheme or beneficiary of such a scheme * Having signed a free informed consent in writing * Hospitalized in PRM for a foreseeable period of at least 60 days * Living space compatible with the movement of the robot (verified by a home visit by the center's occupational therapist) and equipped with wifi * Cognitive and motor functions compatible with the use of the tablet or phone independently, with learning capabilities to use the robot and the completion of questionnaires and interviews remotely * Medically stable Exclusion Criteria: * Subject being in a period of exclusion from another protocol * Mood and behavior disorders not stabilized * Insufficient command of the French language * Protected adults (guardianship / curatorship) * Pregnant or breastfeeding women * Persons deprived of their liberty * Being unable to issue their consent * Person who has already presented a form of addiction to technologies and / or video games

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cognitive disability are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CMPR Côte d'Amour

    Saint-Nazaire, Pays de la Loire Region, 44600, France

  • CMRRF de Kerpape

    Ploemeur, Brittany Region, 56270, France

  • CR Mulhouse

    Mulhouse, Alsace, 68100, France

  • IUR Clémenceau

    Strasbourg, Alsace, 67000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.